New antibody drug targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-stage study tests a new drug called BA3182 in people with advanced adenocarcinoma, a type of cancer that has spread and cannot be removed by surgery. The main goals are to check the drug's safety and see if it can shrink tumors. About 168 adults will take part to find …
Phase: PHASE1 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated May 17, 2026 02:07 UTC